Business Context and Reporting Period
This Form 8-K filing by Nephros, Inc. (NEPH) reports a significant executive leadership change effective November 1, 2023. The filing details the appointment of a new Chief Financial Officer (CFO) and the concurrent resignation of the previous CFO.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on personnel changes and compensation arrangements.
Material Changes
- Appointment of CFO: Judy Krandel was appointed as Chief Financial Officer, effective November 1, 2023.
- Resignation of CFO: Andrew Astor resigned as Chief Financial Officer on November 1, 2023. He is expected to remain with the company until approximately December 31, 2023, to assist with the transition.
- Compensation Structure:
- Base Salary: $140,000 annually.
- Performance Bonus: Targeted at 25% of the annualized base salary.
- Equity Grant: A 10-year stock option to purchase 122,524 shares of common stock as an inducement grant.
- Exercise Price: $1.71 per share (closing price on November 1, 2023).
- Vesting Schedule: 25% vests on the first anniversary of the grant date; the remaining 75% vests in twelve approximately equal quarterly installments thereafter.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, outlook, or management commentary regarding business strategy. No specific risks or contingencies related to the company's operations are disclosed in this report, other than the standard transition period for the CFO role.
Investor Verification Checklist
- Verify the full text of the Employment Agreement and Inducement Award, which are referenced as exhibits to be filed in the upcoming Form 10-K.
- Confirm the transition timeline for Andrew Astor's departure and Judy Krandel's full assumption of duties.
- Review the press release (Exhibit 99.1) for any additional context on the leadership change.
- Monitor future filings for the impact of the new CFO on financial reporting and strategic direction.